Clear Acne Face Moisturizer

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the text.

Uses and Indications

This drug is indicated for the treatment of acne. It is intended for use in patients diagnosed with this condition to help manage and reduce the severity of acne symptoms.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleansed prior to the application of the medication. The medication should be applied as a thin layer to cover the entire affected area.

Initially, it is recommended to start with one application per day. Depending on the patient's response and as directed by a physician, the frequency may be gradually increased to two or three times daily.

In cases where bothersome dryness or peeling occurs, it is advisable to reduce the application frequency to once daily or every other day.

For pediatric patients under the age of 10, consultation with a physician is required before initiating treatment.

Contraindications

Use of this product is contraindicated in the following situations:

• If irritation persists, discontinue use and consult a physician.

• Avoid unnecessary sun exposure; the use of sunscreen is recommended.

• Contact with the eyes should be avoided; in case of contact, rinse eyes thoroughly with water.

• Concurrent use with other topical acne medications may lead to increased dryness or irritation of the skin. Only one medication should be used at a time unless otherwise directed by a healthcare professional.

Warnings and Precautions

For external use only. It is imperative that this product is not ingested. In the event of accidental swallowing, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Healthcare professionals should advise patients to discontinue use and consult their physician if any irritation persists. Continuous monitoring of the patient's response to the treatment is recommended to ensure safety and efficacy.

Side Effects

Patients should be advised that the product is for external use only. In the event that irritation persists, it is recommended that they stop using the product and consult a healthcare professional.

Drug Interactions

Concurrent use of other topical acne medications may lead to increased dryness or irritation of the skin when used simultaneously or immediately after the application of this product. In such cases, it is advisable to limit the use to one medication at a time unless otherwise directed by a healthcare professional. Monitoring for signs of excessive dryness or irritation is recommended to ensure patient comfort and treatment efficacy.

Packaging & NDC

Below are the non-prescription pack sizes of Clear Acne Face Moisturizer (acne face moisturizer). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 10 years of age should be evaluated by a physician prior to use. It is essential to consider the specific needs and potential risks associated with this age group when determining treatment options.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information regarding the use of Clear Acne Face Moisturizer during pregnancy. The prescribing information does not provide safety concerns, dosage modifications, or special precautions for pregnant patients. Therefore, healthcare professionals should exercise caution when recommending this product to women of childbearing potential. It is advisable to consider the lack of data and to discuss potential risks and benefits with patients who are pregnant or planning to become pregnant.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication. It is advisable to monitor breastfed infants for any potential effects, although no specific concerns have been identified in the available information.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

If available, the use of specific antidotes or treatments should be considered based on the substance involved and the clinical presentation. Consultation with a poison control center or toxicology expert may be beneficial in guiding management decisions.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective treatment and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients that if they experience persistent irritation, they should discontinue use and consult a doctor.

Patients should be counseled on the importance of avoiding unnecessary sun exposure while using this product and to apply sunscreen to protect their skin. Additionally, healthcare providers should emphasize the need to avoid contact with the eyes. In the event of accidental eye contact, patients should rinse their eyes thoroughly with water.

Furthermore, healthcare providers should inform patients that using other topical acne medications concurrently or immediately after applying this product may lead to increased dryness or irritation of the skin. If such reactions occur, patients should be advised to use only one medication at a time unless otherwise directed by a healthcare professional.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light exposure to protect its quality. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically. Clinicians should counsel patients to avoid unnecessary sun exposure and to use sunscreen to protect the skin. Patients are advised to avoid contact with the eyes; in the event of contact, they should rinse their eyes thoroughly with water. The concurrent use of other topical acne medications may lead to increased dryness or irritation; therefore, it is recommended that only one medication be used at a time unless directed otherwise by a physician. Additionally, for children under 10 years of age, consultation with a physician is advised.

Drug Information (PDF)

This file contains official product information for Clear Acne Face Moisturizer, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)